B

시지메드텍

056090KOSDAQ

65.8 / 100

Reference Date: 2026-09-08

Financial Score22.5 / 40
News Sentiment21.3 / 25
Momentum12.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 12.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Sijimedtec operates in two main business divisions: medical devices and electrical energy. In the medical devices sector, the company has developed a range of products including spinal fixation devices, fracture treatment devices, and biodegradable implants, and has expanded into dental implants through acquisitions. In the electrical energy division, the company has secured technology in smart grids and EV charging infrastructure, and participates in government-led projects.

Number of Employees

118people

Average Salary

51.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
18.78Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
1.30Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE
7.19Industry Average 8.002.5Point

Below industry avg

Debt Ratio
4.51Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲17.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲236.4% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 3.1% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 1,183Won52-week high 3,35052-week low 864
1-month return5.0Point

1m +12.56% (rising)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-09-07
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral임시주주총회결과2026-08-11